Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2023 Jun 16;173:113678. doi: 10.1016/j.chaos.2023.113678

Endemic oscillations for SARS-CoV-2 Omicron—A SIRS model analysis

Florian Nill 1
PMCID: PMC10272968  PMID: 37351485

Abstract

The SIRS model with constant vaccination and immunity waning rates is well known to show a transition from a disease-free to an endemic equilibrium as the basic reproduction number r0 is raised above threshold. It is shown that this model maps to Hethcote’s classic endemic model originally published in 1973. In this way one obtains unifying formulas for a whole class of models showing endemic bifurcation. In particular, if the vaccination rate is smaller than the recovery rate and r<r0<r+ for certain upper and lower bounds r±, then trajectories spiral into the endemic equilibrium via damped infection waves. Latest data of the SARS-CoV-2 Omicron variant suggest that according to this simplified model continuous vaccination programs will not be capable to escape the oscillating endemic phase. However, in view of the strong damping factors predicted by the model, in reality these oscillations will certainly be overruled by time-dependent contact behaviors.

MSC: 34C23, 34C26, 37C25, 92D30

Keywords: SIRS model, Endemic bifurcation, Endemic oscillations, SARS-Cov-2 Omicron


All models are wrong, but some are useful

George E.P.Box

1. Introduction

According to actual estimates the basic reproduction number r0 for the Delta- and Omicron-variants of Covid-19 ranges between r0,Delta59 and r0,Omicron714.1 Experts therefore seem to agree, that Omicron will completely take over and cause Covid-19 to run into an endemic scenario no matter how strong contact preventing and/or vaccination measures are enforced. For an epidemiological discussion of the transition to endemicity for Covid-19 see [1]. As explained by the authors, when approaching the endemic limit prevalence typically does not decrease monotonically, but there are several waves of infection. These are affected by non-pharmaceutical interventions, increased transmissibility due to virus evolution and of course intrinsic seasonality in transmission. The purpose of the present paper is to analyze when and to what extend damped oscillations would also be predicted by a classic autonomous (i.e. with static coefficients) endemic SIR-type model.

The simplest model to study this question is the so-called SIRS model furnished with an immunity waning rate α and a vaccination rate σ. The model is based on the classic SIR model of Kermack and McKendrick [2], where a population of size N is assumed to be divided into three compartments S (susceptible), I (infectious) and R (recovered and/or immune) such that N=S+I+R. The dynamics of the disease is modeled by an infection flow from S to I, a recovery flow from I to R, a loss of immunity flow from R to S and a vaccination flow from S to R, see Fig. 1. Simplifying assumption are

Fig. 1.

Fig. 1

Flow diagram of a SIRS model with effective contact rate β, recovery rate γ, vaccination rate σ, immunity waning rate α and balanced birth and death rates δ.

  • -

    All three compartments are homogeneously mixed within population.

  • -

    The average number β of effective contacts per day (i.e. contacts leading to an infection given the contacted was susceptible) of an infectious person is constant in time and independent of N.2 So the transmission rate as the (time dependent) number of secondary infections per day caused by a single infectious individual is given by βS/N.

  • -

    The incubation time is neglected, i.e. exposed people are considered susceptible.

  • -

    The time of infectiousness3 is distributed exponentially with mean time Tinf=γ-1, where γ>0 is the recovery (more precisely: infectiousness waning) rate.

  • -

    Recovered persons start immune in R, but loss of immunity brings them back to S. The duration of immunity is also distributed exponentially with mean duration Timm=α-1, where α>0 is the immunity waning rate.

  • -

    A constant fraction σ of susceptibles gets vaccinated per day. Vaccinated and recovered people behave the same way.

  • -

    The population size N is assumed constant, so at the end births and deaths are neglected. But to start the discussion more generally, at first I will also include a balanced demographic birth and death rate δ, where for simplicity the death rate is assumed independent of the compartments and newborns are assumed susceptible.

Given these assumptions one is lead to the following ODE:

dS/dt=βSI/N(σ+δ)S+αR+δN, (1.1)
dI/dt=βSI/N(γ+δ)I, (1.2)
dR/dt=σS+γI(α+δ)R. (1.3)

Note that by construction the total population size is a constant of motion, dN/dt=0. In principle one could also consider SIS-type models, where recovery does not lead to immunity and hence flows from IS. The methods of this paper would apply to such a model as well [3]. More complex models may also contain an exposed compartment E (SEIRS model) to consider incubation time or a separate vaccination compartment V to distinguish immunity after vaccination from immunity after recovery.

As has first been shown by Hethcote [4] (see also [5], [6]), for δ>0 already the model without vaccination and loss of immunity, α=σ=0, shows a bifurcation from a stable disease-free equilibrium point (EP) to a stable endemic scenario when raising the basic reproduction number above one. The same holds true for α>0 and δ0, which may be understood intuitively since loss of immunity acts like dying away from R and being newborn into S. Nowadays the case α=σ=0 and δ>0 is considered as Hethcote’s classic endemic model.

Usually endemic models are used for studying diseases over longer periods, during which there is a renewal of susceptibles by births or falling back from temporary immunity causing diseases to return in (damped) periodic waves [7]. As contact rates become very large and/or duration of immunity relatively small, the frequency of these waves increases. Surveys of more general models with periodic behavior are given in [8] and [9]. These models also include nonlinear incidence, temporary immunity by time delay methods or explicitly periodic parameters. Models with varying population size, in particular also disease induced mortality, have been analyzed e.g. in [10] and [11]. When considering vaccination the simplest way is of course statically, i.e. in the sense of initial conditions on the size of the immune compartment R in order to acquire herd immunity. But the shorter the expected duration of immunity the more important becomes the role of constant vaccination models.

Meanwhile there are plenty of papers generalizing Hethcote’s original ideas, partly also not being aware of each other. The following list is without claim for completeness and with apologies for the unavoidably overlooked ones.

For SIRS/SIS models without vaccination see e.g. [12] or [13]. A SIS-version of (1.1)(1.3) with varying population size has been analyzed by Li and Ma [14] and in [15] the authors have proposed a generalization modeling waning immunity by a time-delay differential equation. In [16] and [17] the authors have added a vaccination term to the classic endemic model, unfortunately without referring to Hethcote’s original work.

Generalizations to SEIR-type models without vaccination have been given e.g. by Li et al. [18], Li and Wang [19], Korobeinikov [20], Li and Jin [21], Korobeinikov [22]. For further generalizations with non-bilinear transmissions see also [23], [24], [25], [26]. SEIR-models including vaccination have been analyzed by Sun and Hsieh [27] and Wang and Xu [28].

A model for booster vaccination with a separate compartment for primary vaccination has been proposed by Rohani and Summers [29] and periodic pulse vaccination has been studied e.g. in [30], [31], [32]. Time dependent vaccination programs have also been studied in [33] by applying optimal control methods and in [34] by letting the vaccination activity be functionally dependent on the prevalence I/N via the Preisach hysteresis operator.

A different approach to modeling partial and/or waning immunity has been proposed by Hadeler and Castillo-Chavez [35], where in a combined SIS/SIRS core group model the authors have introduced a diminished transmission rate directly from R to I. Models with infection transmissions from several compartments may show a so-called backward bifurcation from the disease-free to an endemic scenario [36]. This means that two (or more) equilibrium states may coexist locally stable for some range below threshold, causing also hysteresis effects upon varying parameters. In [37] the authors have extended these results to a combined SIS/SIRS model with vaccination and two immunity waning flows, RS and RI. Distinguishing vaccinated and recovered people into separate compartments, similar results have been obtained by Arino et al. [38]. More recently these ideas have been generalized to a thorough stability analysis of an eight parameter SIRS-type model including varying population size in [39], [40].

Backward bifurcation has lately also been observed in SEIRS-type models for Covid-19 by considering two distinguished susceptible compartments. In [41] the less susceptible compartment had been interpreted as an incomplete lockdown and in [42] as an incomplete vaccination efficacy. A problem for such models of course arises when trying to decide from empirical reinfection data to which loss/absence-of-immunity model the data should fit (i.e. with a flow ISI (SIS-model) or IRSI (SIRS-model) or IRI (the above models)).

Closing this overview I should also remark that backward bifurcation is also observed when considering I-dependent contact or recovery rates to model reactive behavior or infection treatment. However the list of papers on this topic over the last 20 years becomes too huge to be quoted at this place.

In most of the above papers focus is put on questions of stability and thresholds. Although already in Hethcote’s original work [4], [5], [6] the appearance of a spiraling endemic equilibrium node had explicitly been stated, thresholds separating the non-oscillating from the damped-oscillating scenario are rarely given explicitly. Only recently [43] used a variant of the classic endemic model (i.e. without vaccination, with mass incidence and with unbalanced birth and death rates) to apply such thresholds when analyzing historical smallpox waves. For a numerical analysis of a 7-compartment SEIRS-type model with vaccination and waning immunity describing periodic large outbreaks of Mumps in Scotland see [44].

In this paper I will give explicit formulas for the bounds leading to a spiral endemic equilibrium in the SIRS model (1.1)(1.3). On the way I will also show that this model in fact maps to Hethcote’s classic endemic model by a shift-and-rescaling transformation of variables. More generally such a map also exists for models like e.g. a mixed SIRS/SIS model, models with vaccination rate proportional to I and models with unbalanced birth and death rates, vertical transmission and part of the newborns vaccinated [3].

Based on latest data of the SARS-CoV-2 Omicron variant I will then argue that according to this simplified model logistically feasible vaccination programs will most likely not be capable to get this epidemic out of an (albeit strongly damped) oscillating endemic phase. Numerical tables in the Appendix support this picture, while at the same time giving evidence that the damping factor most likely will be too strong for these oscillations to be observed empirically.

2. The classic endemic model

In this Section I will show that for β>0, γδγ+δ>0 and all other parameters non-negative the SIRS model (1.1)(1.3) after a variable transformation looks like the classic endemic model with suitable choices of parameters. So as usual, in a first step we measure time in units of γδ and introduce rescaled variables

τγδt,r0β/γδ,xr0SN,yr0IN. (2.1)

Denoting derivatives w.r.t. τ by dots and replacing R=NSI we end up with the two-dimensional system

x˙=xyaybx+r0c, (2.2)
y˙=xyy, (2.3)

where the new dimensionless parameters a,b,c are given by

aα/γδ,b(α+δ+σ)/γδ,c(α+δ)/γδ. (2.4)

Before proceeding let me shortly recall the meaning of r0 and x. First, according to the standard definition (see e.g. [7] or [45]) in models containing just one infectious compartment the basic reproduction number r0 is given as the expected number of secondary cases produced by a typical infectious individual in a completely susceptible population S=N. So this is the effective contact rate β times the mean time of infectiousness and therefore, in the presence of a death rate, r0=β/(γ+δ), in consistency with (2.1).

Second, according to [7] the replacement number x as a function of time is defined to be the expected number of secondary cases produced by a typical infectious individual during its time of infectiousness. Hence x is given by r0 times the probability of a contact being susceptible,4 x=r0S/N, which coincides with the definition in (2.1). Nowadays the replacement number is mostly called effective reproduction number, but this might lead to misunderstandings, since there is also a notion of a vaccination-reduced reproduction number R0 as a threshold parameter to be explained in Appendix B.

Coming back to the parameters in (2.4), note that they satisfy the constraints

0cb, (2.5)
ac1+a. (2.6)

If one did not look at (2.4) then from (2.5), (2.6) one would also conclude

1ab. (2.7)

Now by definition a seems to be non-negative. But in fact, assume in place of the SIRS model (1.1)(1.3) we had started with the analogous SIS model. Then we would also end up with the system (2.2)(2.3), but in this case the definition of a would be replaced by

a(αγ)/γδ=c11. (2.8)

So in this way we may consider the system (2.2)(2.3) for (x,y)R02 and with constraints (2.5)(2.7) as a master system covering all models of type SIRS or SIS (or mixed) as in (1.1)(1.3), with vaccination rate σ0 and immunity waning rate α0. In particular the classic endemic model corresponds to a=0 and 0<b=c=δ/(γ+δ)<1.

Moreover, it is not difficult to check, that the physical triangle given by S+I+R=N or equivalently

Tphys={(x,y)R02x+yr0} (2.9)

stays forward invariant under the dynamics (2.2)(2.3) provided the constraints (2.5)(2.7) hold.

In the second step I am now going to show that except for the border case a=1 5 we may always rescale to a=0. In fact, there still is a combined “space–time” scaling redundancy in the system (2.2)(2.3) given by the one-parameter group of variable transformations

(x1)λ(x1),yλy,τλ-1τ,λ>0.

This leaves the system (2.2)(2.3) invariant provided the parameters a,b,r0c are also rescaled according to

(a+1)λ(a+1),bλb,(r0cb)λ2(r0cb).

So for a>1 this leads to introducing adapted “normalized” variables

u(τ~)x(τ)+a1+a,v(τ~)y(τ)1+a,τ~(1+a)τ. (2.10)

In terms of these variables the equations of motion become

u˙=uvc1u+c2, (2.11)
v˙=uvv, (2.12)

where now dots denote derivatives w.r.t. τ~ and where the new parameters are given by

c1=b/(1+a)0, (2.13)
c2=(ab+r0c)/(1+a)2=c1+(r0cb)/(1+a)2R. (2.14)

Apparently for c1=δ/(γ+δ) and c2=r0c1 we precisely recover the classical endemic model. The price to pay is that in the SIS-model-case we may have a<0 and hence possibly also negative values of u and c2. Thus, in order to cover the most general setting we have to consider (2.11)(2.12) as a dynamical system on phase space (u,v)R×R0 and the admissible range of parameters is (c1,c2)(R+×R){(0,0)}. In fact, under these conditions the master system (2.11)(2.12) also covers more general models like e.g. a mixed SIRS/SIS model, models with vaccination rate proportional to I, and models with unbalanced birth and death rates, vertical transmission and part of the newborns vaccinated [3].

3. The main theorem

Having reduced a whole class of models to a (marginally extended) version of Hethcote’s classic endemic model standard results now easily carry over. First note that the case c1=0 means σ=α=δ=c2=0 and hence reduces to the classical SIR or SIS model, which here I am not interested in. So from now on assume c1>0 or equivalently α+δ+σ>0.

Now it is important to realize, that given c1>0 and c2R any initial value (u0,v0)R×R0 for the dynamical system (2.11)(2.12) may be considered to lie in the image of some physical triangle Tphys under the transformation (2.10), (2.13)(2.14). Thus for any initial value (u0,v0) the forward time evolution (u(τ~),v(τ~)) under the dynamics (2.11)(2.12) stays bounded and exists for all τ~>0 [3]. This allows to apply standard techniques by using Lyapunov functions and LaSalle’s Invariance Principle, see e.g. [6] or [11].

From now on the way to proceed is straight forward. Writing the master system (2.11), (2.12) in the form p˙=X(p) equilibrium points p are given as zeros of the vector field, X(p)=0. There are precisely two solutions pi=(ui,vi), i=1,2, given by

u1=c2c1,v1=0, (3.1)
u2=1,v2=c2c1. (3.2)

In coordinates (x,y) they correspond to

x1=r0cb,y1=0, (3.3)
x2=1,y2=r0cb1+a, (3.4)

and in terms of the original SIRS-model variables for δ=0

S1/N=αα+σ,I1=0,R1/N=σα+σ (3.5)
r0S2/N=1,r0I2/N=(r01)ασγ+α,r0R2/N=(r01)γ+σγ+α. (3.6)

For c2=c1 the two EPs coincide, p1=p2. As we will see, this threshold marks the transition from the stable disease-free to the stable endemic equilibrium. This motivates to distinguish the following three scenarios (A) - (C)

(A):v2<0u1<1c2<c1x1r0c/b<1r0<1+σ/α,(B):v2=0u1=1c2=c1x1r0c/b=1r0=1+σ/α,(C):v2>0u1>1c2>c1x1r0c/b>1r0>1+σ/α. (3.7)

Here for simplicity the last equivalences are expressed for the case δ=0. Next, local asymptotic behavior near the EP pi is determined by the eigenvalues of the linearized system at pi. Denoting Ti the trace and Di the determinant of the Jacobian DX(pi) and putting ΔiTi24Di we get

T1=c2/c11c1,T2=c2, (3.8)
D1=c1c2,D2=c2c1, (3.9)
Δ1=(c2/c11+c1)2,Δ2=c224c2+4c1. (3.10)

Thus the above scenarios (A) and (C) subdivide into

(A1):c2c1c12c2<c1(A)Δ1>0,(A2):c2=c1c120}(A)Δ1=0,(A3):c2=0c1=1(C1):c2c22/4<c1<c2(C)Δ2>0,(C2):c2c22/4=c1(C)Δ2=0,(C3):c2c22/4>c1(C)Δ2<0. (3.11)

The following unifies various results in the literature as quoted in the introduction.

Theorem 3.1

For (c1,c2)R+×R consider the master system (2.11) (2.12) on R2 .

  • (i)

    In scenario (A) the EP p2=(1,c2c1) is an (unphysical) saddle point and the disease free EP p1=(c2/c1,0) is a stable node which is proper in (A1) , degenerate in (A2) and star in (A3) .

  • (ii)

    In scenario (B) the two equilibria coincide, p1=p2=(1,0) and this EP is non-hyperbolic.

  • (iii)

    In scenario (C) the disease free EP p1 is a saddle point and the endemic EP p2 is a stable node which is proper in (C1) , degenerate in (C2) and spiral in (C3) .

  • (iv)

    In scenarios (A) and (B) the closed upper half-plane {v0} is an asymptotic stability region for p1 and in scenario (C) the open upper half-plane {v>0} is an asymptotic stability region for p2 .

Proof

Parts i)-iii) immediately follow from the definitions (3.11) and the eigenvalue formulas

λi,1/2=12Ti±Δi,Ti=λi,1+λi,2,Di=λi,1λi,2. (3.12)

To prove part iv) one may adapt standard arguments using Lyapunov functions and LaSalle’s Invariance Principle, see e.g. [6] or [11]. A complete proof will be given in [3]. □

Computing eigenvectors also yields asymptotic slopes v˙/u˙ at the EPs. A complete overview is given in Table 1. Here in the case of proper nodes orbits are called “generic” if they are asymptotically tangent to the leading eigenvector. So these are almost all orbits except exactly two tangent to the subleading eigenvector.6

Table 1.

Stable Equilibrium Points (EP).

Scenario/Type EP Eigenvalues λi,1/2 Asympt. Slope Conditions
A1 Proper (u1,v1)=(c2c1,0) λ1,1=c1
0
c2<c1c12(generic orbit)
λ1,2=c2/c11
(c1c12c2)c2
c1>c2>c1c12(v0>0)
A2
Degenerate
λ1,1/2=c11
0
c2=c1c120
A3
Star
λ1,1/2=1
Any value
c1=1,c2=0
B Non-hyperbolic λ1,1=c1
0
c1=c2(v0=0)
λ1,2=0 c1 c1=c2(v0>0)

C1 Proper (u2,v2)=(1,c2c1) λ2,1=12(c2+Δ2)
12(c2+Δ2)
0<Δ2<c22(generic orbit)
λ2,2=12(c2Δ2)
12(c2Δ2)
0<Δ2<c22(special orbit)
C2
Degenerate
λ2,1/2=c2/2
c2/2
Δ2=0
C3 Spiral λ2,1/2=12(c2±Δ2) None Δ2<0

4. The oscillating endemic scenario

By Eq. (3.7) the threshold for endemic bifurcation is given by

r0>b/c=1+σ/α, (4.1)

where the second equality holds for δ=0. So in this Section I will focus on the thresholds for the oscillating endemic scenario (C3). First note that the condition for spiraling, c2c22/4>c1, necessarily requires c1<1 or equivalently b<1+a. Sufficiency is obtained by requiring also lower and upper bounds on r0. Put

r±bc+1+ac1+a±1+ab2. (4.2)

Corollary 4.1

Scenario (C3) is equivalent to b<1+a and r<r0<r+ .

Proof

Using Eqs. (2.13), (2.14), (3.10) we have

Δ2=c224c2+4c1=c2(1+a)4(r0r)(r0r+). (4.3)

Asymptotic values for the decay half-life Thalf and the oscillation period Tosc in scenario (C3) can now be read off from the real/imaginary part of the eigenvalues (last line of Table 1). Recalling τ~=(1+a)γt this gives

γThalf=2log2(1+a)c2=2log2(1+a)r0c+ab, (4.4)
γTosc=4π(1+a)Δ2=4π(1+a)(r0c+ab)2+4(1+a)2(r0cb). (4.5)

Let us now apply this to the SIRS model without vital dynamics, δ=0. As may be seen from the tables in Appendix A (see Fig. 5), for a wide range of parameters Tosc will roughly be 5 times bigger than Thalf. Hence, in the course of one wave cyle amplitudes get already damped by a factor of roughly 0.05. So empirically these waves would most likely be swallowed by noise effects and hence presumably not be observable.

Fig. 5.

Fig. 5

Asymptotic oscillation periods Tosc and decay half-lifes Thalf at fixed vaccination activity avac=0.15. The damping factor gives the asymptotic decay of oscillation amplitudes after one wave cycle. Time scales in days are fixed by assuming the mean time of infectiousness Tinf=4 days.

Moreover, for δ=0 we have a=c=α/γ and b=a+avac where avacσ/γ. Hence

δ=0r±=1+avac/a+(1+a-1)(1+a±1avac)2. (4.6)

Also, in this case b<1+a is equivalent to avac<1. Note that for avac[0,1] we have ±r±/avac<0 and therefore the interval [r,r+] gets narrower as avac increases. Let me call avac the vaccination activity. As will be seen in the next Section for Covid-19 we may safely assume avac<1.

5. Numerical estimates

To get numerical input we now need estimates for γ,a and avac. Since the SIRS model is much too simple to describe reality quantitatively, I will only go for rough estimates to get a feeling for orders of magnitude. The aim is to see, whether empirical data are far from thresholds so the model’s qualitative predictions may be judged realistic. This Section reflects the state of data as of 2022-03-22.

Let us first look at latest studies estimating the mean time of infectiousness, Tinf=γ-1. On 2021-12-22 the UK Health Security Agency (UKHSA) gave new guidance for the public and health and social care staff. In [46] the agency quotes a recent modeling study [47], according to which after 10 full days of self-isolation 5% of people who tested positive for SARS-CoV-2 are still infectious. Numbers reported are also 15.8% after 7 days and 31.4% after 5 days. Mapping these data to an exponential decay as assumed by the SIR model one gets γ 0.30–0.23 corresponding to Tinf 3.4–4.3 days. The above data do not include the Omicron variant of SARS-CoV-2. Mostly Omicron seems to be less severe then Delta indicating shorter recovery times. But in lack of better knowledge let us stay conservative and assume the same range for Omicron.

Concerning estimates on the expected duration of immunity, Timm=α-1, actual studies for Omicron are still volatile and ongoing. For almost weekly updates see e.g. the UKHSA technical briefing documents7 and the COVID-19 vaccine weekly surveillance reports.8 In its technical briefing no. 34 from Jan. 2022 the UKHSA says “estimates suggest that vaccine effectiveness against symptomatic disease with the Omicron variant is significantly lower than compared to the Delta variant and wane rapidly” [48]. In a preprint from Dec. 2021 [49] state “findings indicate that vaccine effectiveness against symptomatic disease with the Omicron variant is significantly lower than with the Delta variant”. Similar findings have also been reported, e.g., by a danish study [50] and in Germany by the STIKO recommendation from 2021-12-21 [51].

Measuring “effectiveness” quantitatively numbers of course depend on the specific vaccine. In [48] it is said that among those who had received 2 doses of Pfizer or Moderna effectiveness dropped from around 65 to 70% down to around 10% by 20 weeks after the 2nd dose. Two to 4 weeks after a booster dose vaccine effectiveness ranged from around 65 to 75%, dropping to 55 to 65% at 5 to 9 weeks and 45 to 50% from 10+ weeks after the booster. Also, at least against Omicron, effectiveness apparently never goes above 75%. Of course the discussion also depends on details like asymptomatic vs. little symptoms or hospitalization etc.

The reinfection risk against Omicron after recovery from Delta also seems to be considerably higher as estimated earlier for Delta–Delta reinfection. Studies published in 2021 still estimated the anti-SARS-CoV-2-directed IgG-antibody half-life between 85 and 160 days [52], [53], [54]. But in [55] authors already claimed their results “indicate that reinfection after natural recovery from COVID-19 will become increasingly common”. In its report no. 49 from Dec. 2021 the Imperial College Covid-19 response team found “strong evidence of immune evasion, both from natural infection, where the risk of reinfection is 5.41 (95% CI: 4.87–6.00) fold higher for Omicron than for Delta, and from vaccine-induced protection [56], see also [49].

So assuming a simple 1-parameter exponential distribution for immunity as in the SIRS model does not quite map the above complexity. Neither does the model distinguish different vaccines nor virus variants nor immunity responses by vaccination vs. recovery. Thus I will plot formulas by assuming a range between 1 and 6 months for the mean duration of immunity Timm, which should be wide enough to cover all reasonable scenarios. Measuring time in units of Tinf this gives Timm/Tinfa-1 7–53.

Finally we need an upper bound for the vaccination activity avac=σ/γ. Fig. 2 shows public data for daily vaccination numbers normalized as fractions of the total population in UK, Germany and Austria. As a common conclusion the daily sum over all dose 1–3 shots rarely ever reaches 1% of the population.

Fig. 2.

Fig. 2

Daily sum of vaccinations over all dose 1 - 3 shots in fractions of population. Links last accessed on 2023-06-21.

Since at that time for most countries a lower bound on the fraction of susceptibles S/N0.25 seems reasonable we get σ<0.04 and therefore avac<0.17 as an upper bound which at least as a time-average should safely hold. In particular avac<1 without any doubt, thus assuring b<1+a as the necessary condition for the oscillating scenario (C3), see Corollary 4.1.

In Fig. 3 lower and upper bounds r± for scenario (C3) are plotted over the range Timm/Tinf[5,50] for values avac=0.05,0.1,0.15 and 0.2. So these lines represent parameter regions for scenario (C2) separating the oscillating endemic scenario (C3) inside [r,r+] from the non-oscillating endemic scenario (C1) outside.

Fig. 3.

Fig. 3

Lower and upper bounds on r0 for a spiral endemic scenario. Fig. (c) shows that for realistic parameter ranges the gap between the endemic threshold b/c=1+avac/a and the lower bound r for spiraling stays below 6%.

At first it is obvious, that the upper bound r+ realistically will never be reached. The conclusion from the lower bound is that for r010 and a mean duration of immunity Timm<160 days (Timm/Tinf<40) it seems hardly possible to escape scenario (C3) (leave alone scenario (C)) by manageable vaccination activities. Lowering the assumption on Timm by 20 days roughly reduces the lower bound on r0 by 1. Also the range between r and the threshold b/c marking the border line to scenario (A) is rather narrow. For better visualization a plot of rc/b is given in Fig. 3c).

6. Summary

In this paper I have shown that SIRS models (and also SIS models) with constant total population and constant vaccination and immunity waning rates (and possibly also with vital dynamics parameters) may be mapped to Hethcote’s classic endemic model, which originally had been based on a balanced birth and death rate only. The only price to pay is an enlarged range of parameter values c1,c2 and (coming from the SIS model) the possibility of negative values for the would-be replacement number variable u. However, these generalizations do not influence the phase structure for equilibrium and stability. Original proofs easily generalize to this master model, thus unifying lots of follow-up proofs on the above models.

I have then applied the SIRS model without vital dynamics to draw conclusions from latest data for the SARS-CoV-2 Omicron variant. In view of actual estimates r0,omikron714 9 already this simplified model explains why the dynamics of Omicron will most likely spiral into an endemic equilibrium. Vaccination programs are capable to reduce the final prevalence I2/N but are unlikely to prevent us from the oscillating scenario or even reach a disease free equilibrium. Yet, for a wide range of parameter values these oscillation effects would be very weak (see damping factors in Fig. 5) and empirically presumably not be distinguishable from the non-oscillating endemic scenarios (C1)-(C2). Tables for endemic prevalence and incidence values predicted by this model are given in Fig. 4.10

Fig. 4.

Fig. 4

Prevalence and incidence tables at the endemic equilibrium for given values of the basic reproduction number r0, the mean time of immunity Timm and the vaccination activity avac. Time scales in days are fixed by assuming the mean time of infectiousness Tinf=4 days.

Of course in many respects this model is too simple to describe reality quantitatively. In reality one has to face different behaviors of virus variants, vaccines, age groups, symptomatic severities and immunity responses by vaccination vs. recovery. Also incubation times are not negligible and estimates for the time of infectiousness are overruled by quarantine measures and hospitalization rates. But most importantly, the effective contact rate β and hence r0 are time varying due to seasonal effects, contact behaviors and regional authority measures. So from this argument alone ongoing seasonal infection waves will completely overrule the weak endemic oscillations predicted by the autonomous SIRS model.

Declaration of Competing Interest

None

1

Determining the basic reproduction number empirically is not an exact science. There are many methods and model dependent definitions and empirical data are volatile. Authors mostly refer to effective reproduction numbers and data also depend on regional authority measures. So in this paper I will only rely on ranges of magnitude. For overviews based on U.S. CDC-reports see https://www.npr.org/sections/goatsandsoda/2021/08/11/1026190062/covid-delta-variant-transmission-cdc-chickenpox/ https://health-desk.org/articles/how-contagious-is-the-delta-variant-compared-to-other-infectious-diseases https://www.cdc.gov/coronavirus/2019-ncov/variants/about-variants.html/ . Also see the CA PHO-report https://www.publichealthontario.ca/-/media/documents/ncov/covid-wwksf/2022/01/wwksf-omicron-communicability.pdf/ .

4

Strictly speaking one should average this probability over the time of infectiousness, but on this time scale S/N may safely be assumed constant.

5

This corresponds to a SIS model with σ0 and α=δ=0, which epidemiologically is uninteresting.

6

For example, if in scenario (A1) the leading eigenvalue is given by λ1,2c2/c11>λ1,1c1 then all orbits with initial condition v0>0 will obey v˙/u˙=(c1c12c2)/c20, whereas an initial condition v0=0 will yield vτ=0 for all τR.

9

Data as of March 2022.

10

Of course one should be aware of under-reporting factors when comparing these values with officially reported numbers. For Germany these factors have lately been estimated between four and five in the first half of 2020 and reduced to roughly two starting with fall 2020, see the RKI-report from Aug. 2021 [57]. Estimates for other countries partly seem to be much larger, for a systematic meta-analysis of 968 international studies with 9.3 Million probands from 76 countries see [58].

11

For sufficient conditions guaranteeing global stability for R0<1 see e.g. [62], [63] or more recently [39].

2

This is the standard incidence assumption. In models with time varying population size N one might also assume a so-called mass-incidence, where β is proportional to N.

3

Loosely speaking also “recovery time”, although this is not quite the same.

Appendix A. SIRS tables at endemic equilibria

This Appendix explains the tables in Fig. 4, Fig. 5. Shown are prevalence and incidence values as well as oscillation periods and decay half-lives predicted by the SIRS model at endemic equilibria. Parameter ranges are r0[5,15], Timm/Tinfa-1[5,50] and avac{0.10,0.15,0.20}. Truly time scales should be interpreted in units of Tinfγ-1. To produce absolute numbers in days I have chosen Tinf=4  days throughout. For other choices of Tinf time scales would have to be rescaled accordingly. The endemic prevalence I2/N is obtained from Eq. (3.6) and the incidence at the endemic equilibrium is given by γI2/N. Formulas for the oscillation period Tosc and the decay-half time Thalf in scenario (C3) have been given in Eqs. (4.4), (4.5).

In Fig. 4, Fig. 5 white cells fall into the disease-free and colored cells into the spiral endemic equilibrium. An exception is the cell r0=8, Timm=180 and avac=0.15 (read border), which belongs to the non-oscillating endemic scenario (C1). In all other border cells scenario (C1) does not appear since parameter ranges for this scenario are too narrow to show up in the chosen resolution.

Appendix B. The vaccination-reduced reproduction number

In models with more than one infectious compartment the notion of basic reproduction number has to be refined. [59], see also [60], have defined a generalized reproduction number R0 given by the spectral radius of the next generation matrix. Using this definition and quite general axioms for compartmental epidemic models [61], [62] have shown that for R0<1 the disease-free equilibrium is locally asymptotically stable and for R0>1 it becomes unstable.11 Moreover, in the case of just one infectious compartment, R0 coincides with the replacement number at the disease-free equilibrium. In our case, by looking at Eq. (3.3), this gives

R0=x1=r0c/b=r0α+δσ+α+δ. (B.1)

Hence Eq. (3.7) verifies the above result, i.e. scenario (C) corresponds to R0r0c/b>1. Also, if we switch off the vaccination term, σ=0, then R0=r0. This is why in SIRS/SIS models R0 is often called the vaccination-reduced reproduction number. Finally, using Eq. (3.4) the formula for the endemic prevalence can now be rewritten as

I2/N=(1R0-1)c1+a=(1R0-1)α+δγ+α+δ, (B.2)

which generalizes the formula in Eq. (3.6) to the case δ>0.

Data availability

Data will be made available on request

References

  • 1.Antia R., Halloran M.E. Transition to endemicity: Understanding COVID-19. Immunity. 2021;54:2172–2176. doi: 10.1016/j.immuni.2021.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kermack W.O., McKendrick A.G. A Contribution to the mathematical theory of epidemics. Proc R Soc Lond A. 1927;115:700–721. [Google Scholar]
  • 3.Nill F. Scaling symmetries and parameter reduction in epidemic SI(R)S models. Symmetry. 2023 doi: 10.20944/preprints202305.2050.v1. to appear, Preprint ( www.preprints.org) [DOI] [Google Scholar]
  • 4.Hethcote H.W. In: Mathematical problems in biology, victoria conference 1973. van den Driessche P., editor. vol. 2. Springer Verlag; Berlin/Heidelberg, Germany: 1974. Asymptotic behavior and stability in epidemic models; pp. 83–92. (Lecture notes in biomathematics). [DOI] [Google Scholar]
  • 5.Hethcote H.W. Qualitative analysis for communicable disease models. Math Biosci. 1976;28:335–356. [Google Scholar]
  • 6.Hethcote H.W. In: Biomathematics. Vol. 18. Levin S.A., Hallam T.G., Gross L.J., editors. Springer Verlag; Berlin, Heidelberg, New York: 1989. Three basic epidemiological models; pp. 119–144. (Applied mathematical ecology). [Google Scholar]
  • 7.Hethcote H.W. The mathematics of infectious diseases. SIAM Rev. 2000;42:599. [Google Scholar]
  • 8.Hethcote H.W., Stech H.W., van den Driessche P. In: Conference on differential equations and applications in ecology, epidemics and population problems. Busenberg S.N., Cooke K.L., editors. Academic Press; New York: 1981. Periodicity and stability in epidemic models: a survey; pp. 65–82. (Differential equations and applications in ecology: Epidemics and population problems). 1981. [DOI] [Google Scholar]
  • 9.Hethcote H.W., Levin S.A. In: Biomathematics. Levin S.A., Hallam T.G., Gross L.J., editors. vol. 18. Springer Verlag; Berlin, Heidelberg, New York: 1989. Periodicity in epidemiological models; pp. 193–211. (Applied mathematical ecology). [Google Scholar]
  • 10.Busenberg S.N., van den Driessche P. Analysis of a disease transmission model in a population with varying size. J Math Biol. 1990;28:257–270. doi: 10.1007/BF00178776. [DOI] [PubMed] [Google Scholar]
  • 11.Mena-Lorca J., Hethcote H.W. Dynamic models of infectious diseases as regulators of population sizes. J Math Biol. 1992;30:693–716. doi: 10.1007/BF00173264. [DOI] [PubMed] [Google Scholar]
  • 12.Korobeinikov A., Wake G.C. Lyapunov functions and global stability for SIR, SIRS, and SIS epidemiological models. Appl Math Lett. 2002;15:955–960. [Google Scholar]
  • 13.O’Regan S.M., Kelly T.C., Korobeinikov A., O’Callaghan M.J.A., Pokrovskii A.V. Lyapunov functions for SIR and SIRS epidemic models. Appl Math Lett. 2010;23:446–448. doi: 10.1016/j.aml.2009.11.014. [DOI] [Google Scholar]
  • 14.Li Jianquan, Ma Zhien. Mathematical and computer modelling. Vol. 35. 2002. Qualitative analyses of SIS epidemic model with vaccination and varying total population size; pp. 1235–1243. [DOI] [Google Scholar]
  • 15.Li Jianquan, Ma Zhien. Stability analysis for SIS epidemic models with vaccination and constant population size. Discr Cont Dyn Syst B. 2004;4:635–642. [Google Scholar]
  • 16.Chauhan S., Misra O.P., Dhar J. Stability analysis of sir model with vaccination. Am J Comput Appl Math. 2014;4(1):17–23. doi: 10.5923/j.ajcam.20140401.03. [DOI] [Google Scholar]
  • 17.Batistela C.M., Ramos M.M., Cabrera M.A.M., Dieguez G.M., Piqueira J.R.C. Vaccination and social distance to prevent Covid-19. IFAC PapersOnLine. 2021;54-15:151–156. doi: 10.1016/j.ifacol.2021.10.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Li M.Y., Graef J.R., Wang L., Karsai J. Global dynamics of a SEIR model with varying total population size. Math Biosci. 1999;160:191–213. doi: 10.1016/s0025-5564(99)00030-9. [DOI] [PubMed] [Google Scholar]
  • 19.Li M.Y., Wang L. In: Mathematical approaches for emerging and reemerging infectious diseases: Models, methods, and theory. Castillo-Chavez C., Blower S., van den Driessche P., Kirschner D., Yakubu A.A., editors. Springer; Berlin Heidelberg New York: 2002. Global Stability in some SEIR epidemic models; pp. 295–311. [Google Scholar]
  • 20.Korobeinikov A. Mathematical medicine and biology. Vol. 21. 2004. Lyapunov functions and global properties for SEIR and SEISS epidemic models; pp. 75–83. [DOI] [PubMed] [Google Scholar]
  • 21.Li Guihua, Jin Zhen. Global stability of a SEIR epidemic model with infectious force in latent, infected and immune period. Chaos Solitons Fractals. 2005;25:1177–1184. doi: 10.1016/j.chaos.2004.11.062. [DOI] [Google Scholar]
  • 22.Korobeinikov A. Global properties of SIR and SEIR epidemic models with multiple parallel infectious stages. Bull Math Biol. 2009;71:75–83. doi: 10.1007/s11538-008-9352-z. [DOI] [PubMed] [Google Scholar]
  • 23.Li M.Y., Muldowney J.S. Global stability for the SEIR model in epidemiology. Math Biosci. 1995;125:155–164. doi: 10.1016/0025-5564(95)92756-5. [DOI] [PubMed] [Google Scholar]
  • 24.Korobeinikov A., Maini P.K. A Lyapunov function and global properties for SIR and SEIR epidemiological models with nonlinear incidence. Math Biosci Eng. 2004;1:57–60. doi: 10.3934/mbe.2004.1.57. [DOI] [PubMed] [Google Scholar]
  • 25.Korobeinikov A. Lyapunov functions and global stability for SIR and SIRS epidemiological models with non-linear transmission. Bull Math Biol. 2006;68:615–626. doi: 10.1007/s11538-005-9037-9. [DOI] [PubMed] [Google Scholar]
  • 26.Sun Chengjun, Lin Yiping. Global stability for an special SEIR epidemic model with nonlinear incidence rates. Chaos Solitons Fractals. 2007;33:290–297. [Google Scholar]
  • 27.Sun Chengjun, Hsieh Ying-Hen. Global analysis of an SEIR model with varying population size and vaccination. Appl Math Model. 2010;34:2685–2697. [Google Scholar]
  • 28.Wang L., Xu R. Global stability of an SEIR epidemic model with vaccination. Int J Biomath. 2016;9 [Google Scholar]
  • 29.Rohani P., Summers A.R. Modelling the effect of a booster vaccination on disease epidemiology. J Math Biol. 2006;52:290–306. doi: 10.1007/s00285-005-0356-0. [DOI] [PubMed] [Google Scholar]
  • 30.Lu Z., Chi X., Chen L. The effect of constant and pulse vaccination on SIR epidemic model with horizontal and vertical transmission. Math Comput Modelling. 2002;36:1039–1057. [Google Scholar]
  • 31.Gao S., Teng Z., Nieto J.J., Torres A. Analysis of an SIR epidemic model with pulse vaccination and distributed time delay. J Biomed Biotechnol. 2007;2007:64870. doi: 10.1155/2007/64870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Shi P., Dong L. Dynamical models for infectious diseases with varying population size and vaccinations. J Appl Math. 2012;2012 doi: 10.1155/2012/824192. [DOI] [Google Scholar]
  • 33.Ledzewicz U., Schättler H. On optimal singular controls for a general SIR- model with vaccination and treatment. Disc Cont Dyn Syst. 2011;2011(Special):981–990. [Google Scholar]
  • 34.Kopfová J., Nábelková P., Rachinskii D., Rouf S.C. Dynamics of SIR model with vaccination and heterogeneous behavioral response of individuals modeled by the Preisach operator. J Mat Biol. 2021;83(11) doi: 10.1007/s00285-021-01629-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hadeler K.P., Castillo-Chavez C. A core group model for disease transmission. Math Biosci. 1995;128:41–55. doi: 10.1016/0025-5564(94)00066-9. [DOI] [PubMed] [Google Scholar]
  • 36.Hadeler K.P., van den Driessche P. Backward bifurcation in epidemic control. Math Biosci. 1997;146:15–35. doi: 10.1016/S0025-5564(97)00027-8. [DOI] [PubMed] [Google Scholar]
  • 37.Kribs-Zaleta C.M., Velasco-Hernandez J.X. A simple vaccination model with multiple endemic states. Math Biosci. 2000;164:183–201. doi: 10.1016/S0025-5564(00)00003-1. [DOI] [PubMed] [Google Scholar]
  • 38.Arino J., Mccluskey C.C., vana den Driessche P. Global results for an epidemic model with vaccination that exhibits backwad bifurcation. SIAM J Appl Math. 2003;64:260–276. doi: 10.1137/S0036139902413829. [DOI] [Google Scholar]
  • 39.Avram F., Adenane R., Bianchin G., Halanay Andrei. Stability analysis of an eight parameter SIR- type model including loss of immunity, and disease and vaccination fatalities. Mathematics. 2022;10(3):402. doi: 10.3390/math10030402. [DOI] [Google Scholar]
  • 40.Avram F., Adenane R., Basnarkov L., Bianchin G., Goreac D., Halanay A. 2021. On matrix-SIR Arino models with linear birth rate, loss of immunity, disease and vaccination fatalities, and their approximations. arXiv preprint, arXiv: http://arxiv.org/abs/2112.03436. [Google Scholar]
  • 41.Nadim S.S., Chattopadhyay J. Occurrence of backward bifurcation and prediction of disease transmission with imperfect lockdown: A case study on COVID-19. Chaos Solitons Fractals. 2020;140 doi: 10.1016/j.chaos.2020.110163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Diagne M.L., Rwezaura H., Tchoumi S.Y., Tchuenche J.M. A mathematical model of COVID-19 with vaccination and treatment. Comput Math Methods Med. 2021;2021 doi: 10.1155/2021/1250129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Greer M., Saha R., Gogliettino A., Yu C., Zollo-Venecek K. Emergence of oscillations in a simple epidemic model with demographic data. R Soc Open Sci. 2020;7:91187. doi: 10.1098/rsos.191187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Hamami D., Cameron R., Pollock K.G., Shankland C. Waning immunity is associated with periodic large outbreaks of mumps: A mathematical modeling study of scottish data. Front Physiol. 2017 doi: 10.3389/fphys.2017.00233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Anderson R.M., May R.M. Population biology of infectious diseases. Part I. Nature. 1979;280:361–367. doi: 10.1038/280361a0. 5721. [DOI] [PubMed] [Google Scholar]
  • 46.UK Health Security Agency . 2022. COVID-19 self-isolation changes: scientific summary. arXiv: https://ukhsalibrary.koha-ptfs.co.uk/wp-content/uploads/sites/40/2022/01/20220110_Self-isolation_Scientific-Summary_Final-clean.pdf. [Google Scholar]
  • 47.Bays D., Whiteley T., Pindar M., Taylor J., Walker B., Williams H., et al. 2021. Mitigating isolation: The use of rapid antigen testing to reduce the impact of self-isolation periods. medRxiv preprint. arXiv: [DOI] [Google Scholar]
  • 48.UK Health Security Agency . 2022. SARS-CoV-2 variants of concern and variants under investigation in England - Technical briefing 34. arXiv: https://ukhsalibrary.koha-ptfs.co.uk/wp-content/uploads/sites/40/2022/01/20220110_Self-isolation_Scientific-Summary_Final-clean.pdf. [Google Scholar]
  • 49.Andrews N., Stowe J., Kirsebom F., Toffa S., Rickeard T., Gallagher E. 2021. Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern. medRxiv preprint arXiv: DOI: [DOI] [Google Scholar]
  • 50.Lyngse F.P., Mortensen L.H. 2021. SARS-CoV-2 Omicron VOC transmission in danish households. medRxiv preprint arXiv: [DOI] [Google Scholar]
  • 51.Harder T., Vygen-Bonnet S., Koch J., Bogdan C., Burchard G. STIKO Germany, Epid Bull. Vol. 2. 2022. STIKO-Empfehlung zur Verkürzung des Impfabstands zwischen Grundimmunisierung bzw. Infektion und Auffrischimpfung auf einen Zeitraum ab 3 Monate und die dazugehörige wissenschaftliche Begründung; pp. 16–18. [DOI] [Google Scholar]
  • 52.Lumley S.F., Wei J., O’Donnell D., Stoesser N.E., Matthews P.C., Howarth A. The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers. Clin Infect Dis. 2021;6 doi: 10.1093/cid/ciab004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Dan J.M., Mateus J., Kato Y., Hastie K.M., Yu E.D., Faliti C.E. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371 doi: 10.1126/science.abf4063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Hartog G. den, et al. Persistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study. Clin Infect Dis. 2021;73:2155–2162. doi: 10.1093/cid/ciab172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Townsend J.P., Hassler H.B., Wang Z., Miura S., Singh J., Kumar S., et al. Lancet microbe 2021. Vol. 2. 2021. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study; pp. e666–e675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Imperial College London; 2021. Growth, population distribution and immune escape of the Omicron in England. Vol. 49. [DOI] [Google Scholar]
  • 57.Neuhauser H., Buttmann-Schweiger N., Ellert U., Fiebig J., Hovener̈ C. Epid bull 2021. Vol. 37. 2021. Seroepidemiologische Studien zu SARS-CoV-2 in Stichproben der Allgemeinbevölkerung und bei Blutspenderinnen und Blutspendern in Deutschland – Ergebnisse bis 2021; pp. 3–12. [DOI] [Google Scholar]
  • 58.Bobrovitz N., Arora R.K., Cao C., Boucher E., Liu M., Donnici C. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis. PLoS One. 2021;16(6) doi: 10.1371/journal.pone.0252617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Diekmann O., Heesterbeek J.A.P., Metz J.A.J. On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J Math Biol. 1990;28:365. doi: 10.1007/BF00178324. [DOI] [PubMed] [Google Scholar]
  • 60.Diekmann O., Heesterbeek J.A.P. Mathematical epidemiology of in-fectious diseases. John Wiley & Sons; West Sussex, England: 2000. (Wiley series in mathematical and computational biology). [Google Scholar]
  • 61.van den Driessche P., Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math Biosci. 2002;180:29–48. doi: 10.1016/s0025-5564(02)00108-6. [DOI] [PubMed] [Google Scholar]
  • 62.van den Driessche P., Watmough J. In: Mathematical epidemiology. Bauer F., van den Driessche P., Wu J., editors. 1945. Further notes on the basic reproduction number; pp. 159–178. (Lecture notes in mathematics). 978-3-540-78910-9. (2008) [DOI] [Google Scholar]
  • 63.Castillo-Chavez C., Feng Z., Huang W. In: Mathematical approaches for emerging and reemerging infectious diseases: Models, methods and theory. Castillo-Chavez C., Blower S., van den Driessche P., Kirschner D., Yakubu A.-A., editors. Springer Verlag; New York: 2002. On the computation of R0 and its role on global stability; pp. 229–250. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data will be made available on request


Articles from Chaos, Solitons, and Fractals are provided here courtesy of Elsevier

RESOURCES